Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
ML-299 is a dual inhibitor of phospholipase D1 (PLD1) and PLD2 (IC50s = 6 and 20 nM, respectively).1 It is selective for PLD1 and PLD2 over a panel of 65 receptors but also inhibits human-ether-a-go-go (hERG), also known as Kv11.1, as well as κ- and µ-opioid receptors at 10 µM.2 ML-299 (1 and 10 µM) decreases invasive migration of U87MG glioblastoma cells.1
WARNING This product is not for human or veterinary use.
1. Development of dual PLD1/2 and PLD2 selective inhibitors from a common 1,3,8-
2. Development of a selective, allosteric PLD1/2 inhibitor in a novel scaffold. P01 ES013125, 1-4 (2013).